Skip to main content

Oncosec Medical Inc

ONCSDelisted Jul 10, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001444307

Oncosec Medical Inc was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Feb 9, 2023; 23 institutions reported holding it in 13F filings for Q3 2022, worth $2.51M in total; no superinvestor held it.

Holders of 5% or more of ONCS

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Oncosec Medical Inc, largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Oncosec Medical Inc on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

9 Schedule 13D and 13G filings on Oncosec Medical Inc, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on ONCS
Filed (ET)FilerFormStakeChangeEvent dateFiling
Feb 13, 2024Szop Multistrat LP13G/AOld format–––SEC
May 25, 2023Intracoastal Capital, LLC13GOld format–New–SEC
May 19, 2023SZOP Multistrat Management LLC13GOld format–New–SEC
Apr 17, 2023Lind Global Fund II LP13GOld format–New–SEC
Feb 14, 2023Avidity Partners Management LP13G/AOld format–––SEC
Feb 14, 2022Avidity Partners Management LP13G/AOld format–––SEC
Feb 23, 2021Alpha Holdings, Inc.13D/AOld format–––SEC
Feb 16, 2021Avidity Partners Management LP13G/AOld format–––SEC
Feb 12, 2021Altium Capital Management LP13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Oncosec Medical Inc shares.

No Form 144 notices for Oncosec Medical Inc are on file.